1. Home
  2. QNRX vs PCLA Comparison

QNRX vs PCLA Comparison

Compare QNRX & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

N/A

Current Price

$4.20

Market Cap

11.6M

Sector

Health Care

ML Signal

N/A

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$5.68

Market Cap

13.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNRX
PCLA
Founded
2018
2008
Country
United States
Japan
Employees
N/A
55
Industry
Medical/Dental Instruments
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.6M
13.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
QNRX
PCLA
Price
$4.20
$5.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.2K
2.0M
Earning Date
05-07-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.10
$0.12
52 Week High
$41.80
$14.10

Technical Indicators

Market Signals
Indicator
QNRX
PCLA
Relative Strength Index (RSI) 33.91 47.14
Support Level N/A $0.78
Resistance Level $6.84 $8.00
Average True Range (ATR) 0.49 2.26
MACD 0.03 -0.36
Stochastic Oscillator 8.17 0.00

Price Performance

Historical Comparison
QNRX
PCLA

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: